Sanofi and Regeneron in immuno-oncology push
July 28, 2015Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1
Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …
Rising to meet the infectious disease challenge
July 27, 2015Manufacturing and Production, Research and Development, Sales and Marketing Antibiotics, R&D, antibiotic resistance, infectious disease
Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …
FDA and EMA approve heart drug Praluent
July 27, 2015Sales and Marketing EMA, FDA, PCSK9, Regeneron, Sanofi, high cholesterol, praluent
The FDA and the EMA have both approved Sanofi and Regeneron’s new high cholesterol drug Praluent. Regulators on both sides …
Novartis Foundation confirms Dr Joerg Reinhard as new chairman
July 27, 2015Manufacturing and Production, Medical Communications Dr Joerg Reinhardt, Novartis
The Novartis Foundation has confirmed several new members of its board of trustees, including a new chairman in Dr Joerg …
Teva to switch generics focus to Allergan
July 27, 2015Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions
Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …
FDA approves Novartis drug Odomzo
July 27, 2015Sales and Marketing Novartis, Odomzo, basal cell carcinoma, skin cancer
The FDA has given the Swiss firm the go-ahead to market its drug for skin cancer. Odomzo (sonidegib, formerly LDE225) …
EMA backs GSK’s malaria vaccine for use in Africa
July 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization
GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …
EMA in push for more paediatric drug trials
July 24, 2015Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics
The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
European Commission approves Merck’s Keytruda for melanoma drug
July 23, 2015Sales and Marketing
The European Commission has approved Merck’s Keytruda (pembrolizumab) as a skin cancer treatment. Keytruda, the company’s successful anti-PD-L1 therapy and …
Cancer and immunology drugs drive strong Roche sales performance
July 23, 2015Sales and Marketing Roche, Severin Schwan, financials
Sales at Roche rose 6% in the first half of 2015, buoyed by “significant growth of sales and immunology medicines”, …
Lilly, Biogen and Roche debut Alzheimer’s disease drug results
July 22, 2015Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly
Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …
BMS halts Opdivo kidney cancer trial early
July 22, 2015Research and Development BMS, Bristol-Myers Squibb, European Commission, Kidney cancer, opdivo, renal cell carcinoma
Bristol-Myers Squibb has stopped its Phase III study of its immunotherapy drug Opdivo in people with kidney cancer early after …
Cancer Drugs Fund assessment to be handed over to NICE
July 22, 2015Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness
NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
New ABPI executive director appointed
July 21, 2015Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Richard Corbett
The UK pharma trade body the ABPI has appointed Richard Corbett as its new executive director of commercial. Corbett will …
Parliamentary launch for UK life sciences group
July 21, 2015Manufacturing and Production, Research and Development All Party Parliamentary Group on Life Sciences, Kit Malthouse, george freeman, government, lobbying, parliament
A Parliamentary body has been created to highlight the contribution the life sciences sector makes to the economy, and boost …
Amgen’s Repatha wins PCSK9 heart drug race
July 21, 2015Sales and Marketing Amgen, European Commission, PCKS9, Repatha, evolocumab, high cholesterol
The European Commission has signed off on Amgen’s Repatha, making it the first in a new class of cholesterol-lowering drugs …
Sandoz and pharma division boost Novartis sales
July 21, 2015Sales and Marketing Alcon, Novartis, Sandoz, financial performance, financial results, income, profits, sales
Sales at Novartis reached $12.7 billion in the second quarter of 2015, while its operating income was $2.3 billion, the …
Novartis and Pfizer to close factories in India
July 21, 2015Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing
Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …
FDA bans drug imports from Indian plant
July 21, 2015Manufacturing and Production Emcure, FDA, GMP, Good Manufacturing Practices, India, compliance, manufacturing, production, safety
The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …
Valeant in $800 million deal for Amoun Pharma
July 20, 2015Sales and Marketing Amoun, Egypt, MENA, Valeant, acquisitions
Valeant is striking out in the acquisitions market yet again, having agreed an $800 million deal to buy Egypt’s largest …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
